Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2005 Jan;60(1):32–38. doi: 10.1136/thx.2004.022244

Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status

M Spruit 1, M Thomeer 1, R Gosselink 1, T Troosters 1, A Kasran 1, A Debrock 1, M Demedts 1, M Decramer 1
PMCID: PMC1747159  PMID: 15618580

Abstract

Background: Skeletal muscle weakness is assumed to be present in patients with sarcoidosis but has never been reported in a consecutive group of patients. Moreover, its relationship with previously observed exercise intolerance and reduced health status has never been studied in these patients.

Methods: Pulmonary function, skeletal and respiratory muscle forces, peak and functional exercise capacity, health status, and the circulating levels of inflammatory and anabolic markers were determined in 25 patients with sarcoidosis who complained of fatigue (15 men) and in 21 healthy subjects (13 men).

Results: Patients with sarcoidosis had lower respiratory and skeletal muscle forces, reduced exercise capacity and health status, higher anxiety and depression scores, and higher circulating levels of tumour necrosis factor-α than healthy subjects (all p⩽0.01). Its soluble receptor p75 tended to be higher (p = 0.04). Circulating levels of interleukin (IL)-6, IL-8, insulin-like growth factor I and its binding protein 3 were not significantly different between the two groups. Skeletal muscle weakness was related to exercise intolerance, depression, and reduced health status in patients with sarcoidosis, irrespective of age, sex, body weight and height (p⩽0.05). Quadriceps peak torque was inversely related to fatigue but not to the circulating levels of inflammatory or anabolic markers. The mean daily dose of corticosteroids received in the 6 month period before testing was related to quadriceps peak torque only in patients who received oral corticosteroids.

Conclusion: Skeletal muscle weakness occurs in patients with sarcoidosis who complain of fatigue and is associated with reduced health status and exercise intolerance.

Full Text

The Full Text of this article is available as a PDF (141.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamopoulos Stamatis, Parissis John, Karatzas Dimitrios, Kroupis Christos, Georgiadis Michael, Karavolias George, Paraskevaidis John, Koniavitou Katerina, Coats Andrew J. S., Kremastinos Dimitrios Th. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol. 2002 Feb 20;39(4):653–663. doi: 10.1016/s0735-1097(01)01795-8. [DOI] [PubMed] [Google Scholar]
  2. Altman D. G., Gore S. M., Gardner M. J., Pocock S. J. Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) 1983 May 7;286(6376):1489–1493. doi: 10.1136/bmj.286.6376.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anker S. D., Swan J. W., Volterrani M., Chua T. P., Clark A. L., Poole-Wilson P. A., Coats A. J. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997 Feb;18(2):259–269. doi: 10.1093/oxfordjournals.eurheartj.a015229. [DOI] [PubMed] [Google Scholar]
  4. Arcasoy S. M., Christie J. D., Pochettino A., Rosengard B. R., Blumenthal N. P., Bavaria J. E., Kotloff R. M. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest. 2001 Sep;120(3):873–880. doi: 10.1378/chest.120.3.873. [DOI] [PubMed] [Google Scholar]
  5. Barry Sinead C., Gallagher Charles G. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol (1985) 2003 Jun 13;95(4):1379–1384. doi: 10.1152/japplphysiol.00506.2002. [DOI] [PubMed] [Google Scholar]
  6. Baughman R. P., Teirstein A. S., Judson M. A., Rossman M. D., Yeager H., Jr, Bresnitz E. A., DePalo L., Hunninghake G., Iannuzzi M. C., Johns C. J. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1885–1889. doi: 10.1164/ajrccm.164.10.2104046. [DOI] [PubMed] [Google Scholar]
  7. Bilici M., Koroglu M. A., Cakirbay H., Guler M., Tosun M., Aydin T., Tan U. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy. Int J Neurosci. 2001 Aug;109(3-4):149–164. doi: 10.3109/00207450108986531. [DOI] [PubMed] [Google Scholar]
  8. Bourjeily-Habr G., Rochester C. L., Palermo F., Snyder P., Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax. 2002 Dec;57(12):1045–1049. doi: 10.1136/thorax.57.12.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chang B., Steimel J., Moller D. R., Baughman R. P., Judson M. A., Yeager H., Jr, Teirstein A. S., Rossman M. D., Rand C. S. Depression in sarcoidosis. Am J Respir Crit Care Med. 2001 Feb;163(2):329–334. doi: 10.1164/ajrccm.163.2.2004177. [DOI] [PubMed] [Google Scholar]
  10. Chang J. A., Curtis J. R., Patrick D. L., Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999 Nov;116(5):1175–1182. doi: 10.1378/chest.116.5.1175. [DOI] [PubMed] [Google Scholar]
  11. Chaudhuri Abhijit, Behan Peter O. Fatigue in neurological disorders. Lancet. 2004 Mar 20;363(9413):978–988. doi: 10.1016/S0140-6736(04)15794-2. [DOI] [PubMed] [Google Scholar]
  12. Cicoira M., Bolger A. P., Doehner W., Rauchhaus M., Davos C., Sharma R., Al-Nasser F. O., Coats A. J., Anker S. D. High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine. 2001 Jul 21;15(2):80–86. doi: 10.1006/cyto.2001.0918. [DOI] [PubMed] [Google Scholar]
  13. Cox Christopher E., Donohue James F., Brown Cynthia D., Kataria Yash P., Judson Marc A. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med. 2003 May 8;168(3):323–329. doi: 10.1164/rccm.200211-1343OC. [DOI] [PubMed] [Google Scholar]
  14. De Becker P., Roeykens J., Reynders M., McGregor N., De Meirleir K. Exercise capacity in chronic fatigue syndrome. Arch Intern Med. 2000 Nov 27;160(21):3270–3277. doi: 10.1001/archinte.160.21.3270. [DOI] [PubMed] [Google Scholar]
  15. DeRemee R. A. Dysphoria and sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1998 Mar;15(1):21–21. [PubMed] [Google Scholar]
  16. Decramer M., de Bock V., Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1958–1964. doi: 10.1164/ajrccm.153.6.8665061. [DOI] [PubMed] [Google Scholar]
  17. Delobbe Alain, Perrault Hélène, Maitre Jocelyne, Robin Sophie, Hossein-Foucher Claude, Wallaert Benoit, Aguilaniu Bernard. Impaired exercise response in sarcoid patients with normal pulmonary functio. Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun;19(2):148–153. [PubMed] [Google Scholar]
  18. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997 Nov;35(11):1095–1108. doi: 10.1097/00005650-199711000-00002. [DOI] [PubMed] [Google Scholar]
  19. Drent M. Sarcoidosis: benefits of a multidisciplinary approach. Eur J Intern Med. 2003 Jul;14(4):217–220. doi: 10.1016/s0953-6205(03)00076-1. [DOI] [PubMed] [Google Scholar]
  20. Drent M., Wirnsberger R. M., Breteler M. H., Kock L. M., de Vries J., Wouters E. F. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1998 Mar;15(1):59–66. [PubMed] [Google Scholar]
  21. Drent M., Wirnsberger R. M., de Vries J., van Dieijen-Visser M. P., Wouters E. F., Schols A. M. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J. 1999 Apr;13(4):718–722. doi: 10.1034/j.1399-3003.1999.13d03.x. [DOI] [PubMed] [Google Scholar]
  22. El Azab S. R., Rosseel P. M. J., de Lange J. J., Groeneveld A. B. J., van Strik R., van Wijk E. M., Scheffer G. J. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth. 2002 Apr;88(4):496–501. doi: 10.1093/bja/88.4.496. [DOI] [PubMed] [Google Scholar]
  23. Emery C. F., Schein R. L., Hauck E. R., MacIntyre N. R. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998 May;17(3):232–240. doi: 10.1037//0278-6133.17.3.232. [DOI] [PubMed] [Google Scholar]
  24. Fernández-Celemín Laura, Pasko Nevi, Blomart Valerie, Thissen Jean-Paul. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab. 2002 Jul 2;283(6):E1279–E1290. doi: 10.1152/ajpendo.00054.2002. [DOI] [PubMed] [Google Scholar]
  25. Fulcher K. Y., White P. D. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):302–307. doi: 10.1136/jnnp.69.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gardner M. J., Altman D. G. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):746–750. doi: 10.1136/bmj.292.6522.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gosselink R., Troosters T., Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996 Mar;153(3):976–980. doi: 10.1164/ajrccm.153.3.8630582. [DOI] [PubMed] [Google Scholar]
  28. Grimes David A., Schulz Kenneth F. An overview of clinical research: the lay of the land. Lancet. 2002 Jan 5;359(9300):57–61. doi: 10.1016/S0140-6736(02)07283-5. [DOI] [PubMed] [Google Scholar]
  29. Guyatt G. H., Berman L. B., Townsend M., Pugsley S. O., Chambers L. W. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 Oct;42(10):773–778. doi: 10.1136/thx.42.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Guyatt G. H., Pugsley S. O., Sullivan M. J., Thompson P. J., Berman L., Jones N. L., Fallen E. L., Taylor D. W. Effect of encouragement on walking test performance. Thorax. 1984 Nov;39(11):818–822. doi: 10.1136/thx.39.11.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hambrecht Rainer, Schulze Paul Christian, Gielen Stephan, Linke Axel, Möbius-Winkler Sven, Yu Jiangtao, Kratzsch J J. ürgen, Baldauf Gerhard, Busse Martin W., Schubert Andreas. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2002 Apr 3;39(7):1175–1181. doi: 10.1016/s0735-1097(02)01736-9. [DOI] [PubMed] [Google Scholar]
  32. Hearth-Holmes M., Campbell G. D., Jr Muscle weakness, fatigue, and joint pain in a 52-year-old woman. Chest. 1995 Aug;108(2):563–564. doi: 10.1378/chest.108.2.563. [DOI] [PubMed] [Google Scholar]
  33. Jamal M. M., Cilursu A. M., Hoffman E. L. Sarcoidosis presenting as acute myositis. Report and review of the literature. J Rheumatol. 1988 Dec;15(12):1868–1871. [PubMed] [Google Scholar]
  34. Jones N. L., Makrides L., Hitchcock C., Chypchar T., McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985 May;131(5):700–708. doi: 10.1164/arrd.1985.131.5.700. [DOI] [PubMed] [Google Scholar]
  35. Lareau S. C., Breslin E. H., Meek P. M. Functional status instruments: outcome measure in the evaluation of patients with chronic obstructive pulmonary disease. Heart Lung. 1996 May-Jun;25(3):212–224. doi: 10.1016/s0147-9563(96)80032-x. [DOI] [PubMed] [Google Scholar]
  36. Medinger A. E., Khouri S., Rohatgi P. K. Sarcoidosis: the value of exercise testing. Chest. 2001 Jul;120(1):93–101. doi: 10.1378/chest.120.1.93. [DOI] [PubMed] [Google Scholar]
  37. Miller A., Brown L. K., Sloane M. F., Bhuptani A., Teirstein A. S. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest. 1995 Feb;107(2):323–329. doi: 10.1378/chest.107.2.323. [DOI] [PubMed] [Google Scholar]
  38. Mozaffar T., Lopate G., Pestronk A. Clinical correlates of granulomas in muscle. J Neurol. 1998 Aug;245(8):519–524. doi: 10.1007/s004150050236. [DOI] [PubMed] [Google Scholar]
  39. Neder J. A., Sword D., Ward S. A., Mackay E., Cochrane L. M., Clark C. J. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax. 2002 Apr;57(4):333–337. doi: 10.1136/thorax.57.4.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Paramothayan Shanthi, Jones Paul W. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA. 2002 Mar 13;287(10):1301–1307. doi: 10.1001/jama.287.10.1301. [DOI] [PubMed] [Google Scholar]
  41. Redelmeier D. A., Guyatt G. H., Goldstein R. S. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol. 1996 Nov;49(11):1215–1219. doi: 10.1016/s0895-4356(96)00206-5. [DOI] [PubMed] [Google Scholar]
  42. SCADDING J. G. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961 Nov 4;2(5261):1165–1172. doi: 10.1136/bmj.2.5261.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sharma S. K., Mohan A., Guleria J. S. Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis. J Assoc Physicians India. 2001 Jul;49:697–704. [PubMed] [Google Scholar]
  44. Sietsema K. E., Kraft M., Ginzton L., Sharma O. P. Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest. 1992 Sep;102(3):838–845. doi: 10.1378/chest.102.3.838. [DOI] [PubMed] [Google Scholar]
  45. Silverstein A., Siltzbach L. E. Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol. 1969 Sep;21(3):235–241. doi: 10.1001/archneur.1969.00480150025002. [DOI] [PubMed] [Google Scholar]
  46. Simpson K., Killian K., McCartney N., Stubbing D. G., Jones N. L. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax. 1992 Feb;47(2):70–75. doi: 10.1136/thx.47.2.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Spruit M. A., Gosselink R., Troosters T., De Paepe K., Decramer M. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J. 2002 Jun;19(6):1072–1078. doi: 10.1183/09031936.02.00287102. [DOI] [PubMed] [Google Scholar]
  48. Spruit M. A., Gosselink R., Troosters T., Kasran A., Gayan-Ramirez G., Bogaerts P., Bouillon R., Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003 Sep;58(9):752–756. doi: 10.1136/thorax.58.9.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Van den Berghe G., Baxter R. C., Weekers F., Wouters P., Bowers C. Y., Veldhuis J. D. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab. 2000 Jan;85(1):183–192. doi: 10.1210/jcem.85.1.6316. [DOI] [PubMed] [Google Scholar]
  50. Wirnsberger R. M., Drent M., Hekelaar N., Breteler M. H., Drent S., Wouters E. F., Dekhuijzen P. N. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J. 1997 Jul;10(7):1450–1455. doi: 10.1183/09031936.97.10071450. [DOI] [PubMed] [Google Scholar]
  51. Ziegenhagen M. W., Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med. 2003 Jan;253(1):18–30. doi: 10.1046/j.1365-2796.2003.01074.x. [DOI] [PubMed] [Google Scholar]
  52. Ziegenhagen M. W., Schrum S., Zissel G., Zipfel P. F., Schlaak M., Müller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med. 1998 Jun;46(5):223–231. [PubMed] [Google Scholar]
  53. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only Appendix and Figures]
thorax_60_1_32__index.html (1.4KB, html)
thorax_60_1_32__1.pdf (114.6KB, pdf)
thorax_60_1_32__2.pdf (15KB, pdf)
thorax_60_1_32__3.pdf (13.7KB, pdf)

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES